These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2365778

  • 1. Normal-phase high-performance liquid chromatographic procedure for the determination of diprafenone in plasma.
    Austin D, Koziol T, Woolf E, Espinosa-Crouch G.
    J Chromatogr; 1990 Apr 27; 527(1):182-8. PubMed ID: 2365778
    [No Abstract] [Full Text] [Related]

  • 2. [HPLC determination of diprafenone and its active metabolite 5-hydroxydiprafenone in human plasma].
    Zhong D, Blume H.
    Pharmazie; 1994 Jan 27; 49(1):38-41. PubMed ID: 8140128
    [Abstract] [Full Text] [Related]

  • 3. Enantioselective determination of diprafenone in human plasma.
    Zhong D, Chen R, Fieger-Büschges H, Blume H.
    Pharmazie; 1997 Feb 27; 52(2):106-9. PubMed ID: 9122271
    [Abstract] [Full Text] [Related]

  • 4. Direct separation of the enantiomers of propafenone, diprafenone and their major metabolites by high-performance liquid chromatography on modified cellulose and amylose chiral stationary phases.
    Hollenhorst T, Blaschke G.
    J Chromatogr; 1991 Nov 01; 585(2):329-32. PubMed ID: 1804845
    [No Abstract] [Full Text] [Related]

  • 5. High-performance liquid chromatographic method for the simultaneous determination of propafenone and 5-hydroxypropafenone in human serum.
    Kunicki PK, Paczkowski D, Sitkiewicz D.
    Pol J Pharmacol Pharm; 1992 Nov 01; 44(2):161-71. PubMed ID: 1409116
    [Abstract] [Full Text] [Related]

  • 6. [Simultaneous determination of propafenone and its active metabolite in serum by high performance liquid chromatography].
    Zhang WL, Tang YN.
    Yao Xue Xue Bao; 1992 Nov 01; 27(7):552-5. PubMed ID: 1442090
    [Abstract] [Full Text] [Related]

  • 7. Simultaneous determination of propafenone and 5-hydroxypropafenone enantiomers in plasma by chromatography on an amylose derived chiral stationary phase.
    Pires de Abreu LR, Lanchote VL, Bertucci C, Cesarino EJ, Bonato PS.
    J Pharm Biomed Anal; 1999 Jun 01; 20(1-2):209-16. PubMed ID: 10704025
    [Abstract] [Full Text] [Related]

  • 8. ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning.
    Fonck K, Haenebalcke C, Hemeryck A, Belpaire F, Jordaens L, Calle P, Buylaert W.
    J Toxicol Clin Toxicol; 1998 Jun 01; 36(3):247-51. PubMed ID: 9656983
    [Abstract] [Full Text] [Related]

  • 9. Influence of food on the bioavailability and some pharmacokinetic parameters of diprafenone--a novel antiarrhythmic agent.
    Koytchev R, Alken RG, Mayer O, Smith I, Greenwood M.
    Eur J Clin Pharmacol; 1996 Jun 01; 50(4):315-9. PubMed ID: 8803526
    [Abstract] [Full Text] [Related]

  • 10. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A, Zehender M, Hohnloser S, Landsrath C, Meinertz T, Just H.
    Z Kardiol; 1988 Jul 01; 77(7):464-9. PubMed ID: 2463720
    [Abstract] [Full Text] [Related]

  • 11. High-performance liquid chromatographic analysis of propafenone in human plasma samples.
    Harapat SR, Kates RE.
    J Chromatogr; 1982 Jul 09; 230(2):448-53. PubMed ID: 7107791
    [No Abstract] [Full Text] [Related]

  • 12. High-performance liquid chromatographic separation and mass spectrometric identification of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    Latini R, Sica A, Marchi S, Chen ZM, Gavinelli M, Benfenati E.
    J Chromatogr; 1988 Jan 22; 424(1):211-4. PubMed ID: 3366834
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.
    Trenk D, Wagner F, Sachs W, Jähnchen E.
    Eur J Clin Pharmacol; 1989 Jan 22; 37(3):313-6. PubMed ID: 2612546
    [Abstract] [Full Text] [Related]

  • 14. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
    Groschner K, Lindner W, Schnedl H, Kukovetz WR.
    Br J Pharmacol; 1991 Mar 22; 102(3):669-74. PubMed ID: 1364837
    [Abstract] [Full Text] [Related]

  • 15. A liquid chromatography-electrospray tandem mass spectrometry method for the determination of antiarrhythmic drugs and their metabolites in forensic whole blood samples.
    Sørensen LK.
    J Anal Toxicol; 2012 Mar 22; 36(2):116-22. PubMed ID: 22337781
    [Abstract] [Full Text] [Related]

  • 16. Propafenone poisoning--a case report with plasma propafenone concentrations.
    Ovaska H, Ludman A, Spencer EP, Wood DM, Jones AL, Dargan PI.
    J Med Toxicol; 2010 Mar 22; 6(1):37-40. PubMed ID: 20373066
    [Abstract] [Full Text] [Related]

  • 17. [Electrophysiologic and hemodynamic effects of the new anti-arrhythmia agent diprafenone].
    Gülker H, Heuer H, Thale J, Behrenbeck T.
    Z Kardiol; 1987 Jul 22; 76(7):411-4. PubMed ID: 3673162
    [Abstract] [Full Text] [Related]

  • 18. Internally standardized simultaneous assay of propafenone and 5-hydroxypropafenone enantiomers in human plasma by means of high performance liquid chromatography.
    Kern R.
    Methods Find Exp Clin Pharmacol; 1994 Apr 22; 16(3):203-10. PubMed ID: 7913980
    [Abstract] [Full Text] [Related]

  • 19. Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers.
    Hinderling PH, Tendolkar A, Dee CM, Barr WH, Seiberling M, Duerr H.
    J Clin Pharmacol; 1995 Jul 22; 35(7):721-9. PubMed ID: 7560253
    [Abstract] [Full Text] [Related]

  • 20. Quantitation of Flecainide, Mexiletine, Propafenone, and Amiodarone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Slawson MH, Johnson-Davis KL.
    Methods Mol Biol; 2016 Jul 22; 1383():11-9. PubMed ID: 26660169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.